In an amicus brief filed in Ortho Biotech Products v. United States ex rel. Mark Eugene Duxbury, the AHA said that if the First Circuit Court of Appeals’ decision were not reversed, it would undermine two key requirements for FCA actions:
- That private individuals attempting to bring lawsuits not trade on fraud allegations already disclosed to the public; and
- That they have specific knowledge of false or fraudulent claims before filing the case.
Read AHA News Now’s report on the False Claims Act.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
